{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:06:40Z","timestamp":1769004400765,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,8]]},"DOI":"10.7759\/cureus.77120","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T08:09:27Z","timestamp":1736323767000},"source":"Crossref","is-referenced-by-count":1,"title":["Management of Severe SARS-CoV-2-Associated Organizing Pneumonia With Immunoglobulins"],"prefix":"10.7759","author":[{"given":"Bimaje","family":"Akpa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1325157","article-title":"Cryptogenic organizing pneumonia","volume":"33","author":"Cottin V","year":"2012","unstructured":"Cottin V, Cordier JF. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med. 2012, 33:462-75. 10.1055\/s-0032-1325157","journal-title":"Semin Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1582013","article-title":"Many faces of bronchiolitis and organizing pneumonia","volume":"37","author":"Cordier JF","year":"2016","unstructured":"Cordier JF, Cottin V, Lazor R, Thivolet-B\u00e9jui F. Many faces of bronchiolitis and organizing pneumonia. Semin Respir Crit Care Med. 2016, 37:421-40. 10.1055\/s-0036-1582013","journal-title":"Semin Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9343491","article-title":"A case report of steroid-resistant cryptogenic organizing pneumonia managed with intravenous immunoglobulins","volume":"2021","author":"Dimala CA","year":"2021","unstructured":"Dimala CA, Patel U, Lloyd B, Donato A, Kimmel WB, Hallowell R, Moss C. A case report of steroid-resistant cryptogenic organizing pneumonia managed with intravenous immunoglobulins. Case Rep Pulmonol. 2021, 2021:9343491. 10.1155\/2021\/9343491","journal-title":"Case Rep Pulmonol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2002.10015","article-title":"Update on cryptogenic organising pneumonia (idiopathic bronchiolitis obliterans organising pneumonia)","volume":"132","author":"Cordier JF","year":"2002","unstructured":"Cordier JF. Update on cryptogenic organising pneumonia (idiopathic bronchiolitis obliterans organising pneumonia). Swiss Med Wkly. 2002, 132:588-91. 10.4414\/smw.2002.10015","journal-title":"Swiss Med Wkly"},{"key":"ref5","article-title":"Iatrogenic drug-induced bronchospasm, cough, and bronchiolitis. Etiologic and physiopathologic aspects (Article in French)","volume":"13","author":"Cottin V","year":"1996","unstructured":"Cottin V, Cordier JF. Iatrogenic drug-induced bronchospasm, cough, and bronchiolitis. Etiologic and physiopathologic aspects (Article in French). Rev Mal Respir. 1996, 13:339-60.","journal-title":"Rev Mal Respir"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202008-1002OC","article-title":"Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment","volume":"18","author":"Myall KJ","year":"2021","unstructured":"Myall KJ, Mukherjee B, Castanheira AM, et al.. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021, 18:799-806. 10.1513\/AnnalsATS.202008-1002OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.871","article-title":"Post-coronavirus disease 2019 organizing pneumonia confirmed pathologically by video-assisted thoracoscopic surgery","volume":"9","author":"Sugino K","year":"2021","unstructured":"Sugino K, Ono H, Haraguchi S, Igarashi S, Hebisawa A, Tsuboi E. Post-coronavirus disease 2019 organizing pneumonia confirmed pathologically by video-assisted thoracoscopic surgery. Respirol Case Rep. 2021, 9:e0871. 10.1002\/rcr2.871","journal-title":"Respirol Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ph15121574","article-title":"The hidden pandemic of COVID-19-induced organizing pneumonia","volume":"15","author":"Bazdyrev E","year":"2022","unstructured":"Bazdyrev E, Panova M, Zherebtsova V, Burdenkova A, Grishagin I, Novikov F, Nebolsin V. The hidden pandemic of COVID-19-induced organizing pneumonia. Pharmaceuticals (Basel). 2022, 15:1574. 10.3390\/ph15121574","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0883","article-title":"Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis","volume":"139","author":"Drakopanagiotakis F","year":"2011","unstructured":"Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, et al.. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest. 2011, 139:893-900. 10.1378\/chest.10-0883","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00013505","article-title":"Cryptogenic organising pneumonia","volume":"28","author":"Cordier JF","year":"2006","unstructured":"Cordier JF. Cryptogenic organising pneumonia. Eur Respir J. 2006, 28:422-46. 10.1183\/09031936.06.00013505","journal-title":"Eur Respir J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00810-3","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"401","author":"Huang C","year":"2023","unstructured":"Huang C, Huang L, Wang Y, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2023, 401:e21-33. 10.1016\/S0140-6736(23)00810-3","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1750","article-title":"Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19)","volume":"73","author":"van den Borst B","year":"2021","unstructured":"van den Borst B, Peters JB, Brink M, et al.. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021, 73:e1089-98. 10.1093\/cid\/ciaa1750","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02411-2021","article-title":"Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection","volume":"60","author":"Ravaglia C","year":"2022","unstructured":"Ravaglia C, Doglioni C, Chilosi M, et al.. Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J. 2022, 60:10.1183\/13993003.02411-2021","journal-title":"Eur Respir J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"1","author":"Bonilla FA","year":"2005945","unstructured":"Bonilla FA, Bernstein IL, Khan DA, et al.. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005945, 1:1-63. 10.1016\/s1081-1206(10)61142-8","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60665-5","article-title":"Assessment and clinical interpretation of reduced IgG values","volume":"99","author":"Agarwal S","year":"2007","unstructured":"Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. 2007, 99:281-3. 10.1016\/S1081-1206(10)60665-5","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216088","article-title":"Severe organising pneumonia following COVID-19","volume":"76","author":"Vad\u00e1sz I","year":"2021","unstructured":"Vad\u00e1sz I, Husain-Syed F, Dorfm\u00fcller P, et al.. Severe organising pneumonia following COVID-19. Thorax. 2021, 76:201-4. 10.1136\/thoraxjnl-2020-216088","journal-title":"Thorax"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000430100","article-title":"Successful rituximab therapy in steroid-resistant, cryptogenic organizing pneumonia: a case series","volume":"90","author":"Shitenberg D","year":"2015","unstructured":"Shitenberg D, Fruchter O, Fridel L, Kramer MR. Successful rituximab therapy in steroid-resistant, cryptogenic organizing pneumonia: a case series. Respiration. 2015, 90:155-9. 10.1159\/000430100","journal-title":"Respiration"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00359.2020","article-title":"Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19","volume":"320","author":"Husain-Syed F","year":"2021","unstructured":"Husain-Syed F, Vad\u00e1sz I, Wilhelm J, et al.. Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19. Am J Physiol Lung Cell Mol Physiol. 2021, 320:L590-9. 10.1152\/ajplung.00359.2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-021-00002-8","article-title":"Low admission immunoglobulin G levels predict poor outcome in patients with mild-to-critical COVID-19: a prospective, single-center study","volume":"11","author":"Vrettou CS","year":"2021","unstructured":"Vrettou CS, Vassiliou AG, Kakkas I, et al.. Low admission immunoglobulin G levels predict poor outcome in patients with mild-to-critical COVID-19: a prospective, single-center study. J Epidemiol Glob Health. 2021, 11:338-43. 10.1007\/s44197-021-00002-8","journal-title":"J Epidemiol Glob Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000513198","article-title":"Hyperinflammation and immune response generation in COVID-19","volume":"27","author":"Mishra KP","year":"2020","unstructured":"Mishra KP, Singh AK, Singh SB. Hyperinflammation and immune response generation in COVID-19. Neuroimmunomodulation. 2020, 27:80-6. 10.1159\/000513198","journal-title":"Neuroimmunomodulation"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107046","article-title":"Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: a retrospective cohort study","volume":"144","author":"Gr\u00f6ning R","year":"2024","unstructured":"Gr\u00f6ning R, Walde J, Ahlm C, Forsell M, Normark J, Rasmuson J. Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: a retrospective cohort study. International Journal of Infectious Diseases. 2024, 144:107046.","journal-title":"International Journal of Infectious Diseases"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325058-management-of-severe-sars-cov-2-associated-organizing-pneumonia-with-immunoglobulins","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T08:09:29Z","timestamp":1736323769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325058-management-of-severe-sars-cov-2-associated-organizing-pneumonia-with-immunoglobulins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.77120","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,8]]}}}